SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

GE HealthCare Technologies Inc. GEHCV NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

GE HealthCare Technologies Inc. (GEHCV) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $56.00. It has a SharesGrow Score of 64/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $20.6B, +4%/yr average growth. Net income is $2.1B, growing at +4.5%/yr. Net profit margin is 10.1% (healthy). Gross margin is 40% (+0.9 pp trend).

Balance sheet: total debt is $508M against $10.4B equity (Debt-to-Equity (D/E) ratio 0.05, conservative). Current ratio is 1.18 (adequate). Debt-to-assets is 1.4%. Total assets: $36.9B.

Analyst outlook: 0 / 1 analysts rate GEHCV as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 85/100 (Pass), Growth 45/100 (Partial), Past 100/100 (Pass), Health 67/100 (Partial), Moat 73/100 (Pass), Future 20/100 (Fail), Income 55/100 (Partial).

GEHCV SharesGrow Score Overview

64/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 85/100

Valuation — P/E, PEG, Forward PEG

GROWTH 45/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 73/100

Gross margin is + market cap

FUTURE 20/100

Analyst outlook — as buy

INCOME 55/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — GEHCV

GEHCV trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

GEHCV: +4%/yr revenue is, +4.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

GEHCV: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet GEHCV: Debt-to-Equity (D/E) ratio 0.05 (conservative), Current ratio is 1.18 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

GEHCV: Gross margin is 40% (+0.9 pp trend), $25B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 73/100. ≥ 70 = Pass.

View details →

Analyst outlook: 0 / 1 analysts rate GEHCV as buy (0%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

GEHCV: Net profit margin is 10.1%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range53.0-66.28

Volume1.79M

Avg Volume (30D)4.15M

Market Cap$25.46B

Beta (1Y)0.00

Share Statistics

EPS (TTM)4.56

Shares Outstanding$456M

IPO Date2022-12-15

Employees51,000

CEOPeter J. Arduini

Financial Highlights & Ratios

Revenue (TTM)$20.63B

Gross Profit$8.25B

EBITDA$2.76B

Net Income$2.08B

Operating Income$2.76B

Total Cash$4.51B

Total Debt$508M

Net Debt$-4B

Total Assets$36.91B

Price / Earnings (P/E)12.3

Price / Sales (P/S)1.23

Analyst Forecast

Rating ConsensusHold

Analysts Covering1

Buy 0% Hold 100% Sell 0%

Company Info

CountryUS

ExchangeNASDAQ Global Select

CurrencyUSD

Price Chart

GEHCV

GE HealthCare Technologies Inc. ↗ · NASDAQ Global Select

Healthcare • Medical - Healthcare Information Services

53.00 52WK RANGE 66.28

People Also View

Eli Lilly and Company

Johnson & Johnson

Roche Holding AG

Roche Holding AG

AstraZeneca PLC

Merck & Co., Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message